Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 22 10:44AM ET
2.85
Dollar change
+0.07
Percentage change
2.52
%
Index- P/E- EPS (ttm)-0.91 Insider Own51.93% Shs Outstand9.39M Perf Week3.26%
Market Cap32.80M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.54M Perf Month39.71%
Income-7.94M PEG- EPS next Q-0.19 Inst Own1.36% Short Float1.00% Perf Quarter88.74%
Sales2.53M P/S12.97 EPS this Y-4.40% Inst Trans252.73% Short Ratio0.25 Perf Half Y111.11%
Book/sh0.52 P/B5.51 EPS next Y- ROA-77.80% Short Interest0.06M Perf Year56.59%
Cash/sh0.25 P/C11.63 EPS next 5Y- ROE-99.84% 52W Range0.95 - 3.62 Perf YTD93.81%
Dividend Est.- P/FCF- EPS past 5Y-19.28% ROI-132.87% 52W High-21.27% Beta2.64
Dividend TTM- Quick Ratio1.76 Sales past 5Y13156.86% Gross Margin21.40% 52W Low198.49% ATR (14)0.27
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM9.30% Oper. Margin-314.84% RSI (14)64.10 Volatility12.26% 10.84%
Employees75 Debt/Eq0.33 Sales Y/Y TTM52638.42% Profit Margin-313.41% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.23 EPS Q/Q-28.48% Payout- Rel Volume0.48 Prev Close2.78
Sales Surprise22.22% EPS Surprise-35.00% Sales Q/Q94245.95% EarningsApr 01 BMO Avg Volume216.21K Price2.85
SMA2016.92% SMA5037.17% SMA20069.03% Trades Volume24,074 Change2.52%
Apr-09-24 08:00AM
Apr-01-24 10:53PM
09:49AM
Mar-08-24 01:15PM
12:45PM
10:45AM Loading…
Mar-06-24 10:45AM
09:46AM
Mar-05-24 08:00AM
Feb-21-24 08:00AM
Feb-06-24 08:00AM
Jan-30-24 08:00AM
Jan-23-24 08:00AM
Jan-08-24 08:00AM
Jan-05-24 09:00AM
Dec-05-23 08:00AM
08:00AM Loading…
Nov-30-23 08:00AM
Nov-28-23 08:00AM
Nov-15-23 08:00AM
Nov-14-23 04:01PM
Nov-06-23 08:00AM
Oct-10-23 08:00AM
Sep-21-23 09:35AM
Sep-19-23 08:00AM
Sep-07-23 08:00AM
Aug-14-23 05:03PM
Jul-12-23 08:00AM
Jun-15-23 08:00AM
May-22-23 08:00AM
May-15-23 08:00AM
May-01-23 08:00AM
08:00AM Loading…
Apr-25-23 08:00AM
Apr-05-23 08:00AM
Mar-31-23 05:52PM
Mar-28-23 08:00AM
Mar-24-23 08:00AM
Feb-13-23 08:00AM
Jan-24-23 08:00AM
Jan-04-23 08:00AM
Dec-19-22 11:33AM
Dec-15-22 08:30AM
Dec-01-22 08:00AM
Nov-14-22 07:30AM
Nov-10-22 08:15AM
Nov-08-22 08:00AM
Oct-25-22 09:15AM
Oct-12-22 08:15AM
Sep-28-22 08:15AM
Sep-14-22 08:15AM
Sep-06-22 01:54PM
11:28AM
Sep-01-22 12:32PM
08:15AM
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson Robert A.DirectorFeb 26 '24Option Exercise1.1664,84874,899121,856Mar 29 04:52 PM